Churchill Capital (CCXI)

Nasdaq Market Open

Churchill Capital Corp XI is a special purpose acquisition company, or SPAC, formed to take a private business public through a merger, share exchange, asset acquisition, reorganisation, or similar transaction. As a blank check company, it does not operate a commercial business of its own at the time of listing. Its value proposition rests on the sponsor’s ability to identify an attractive target, negotiate a transaction, and complete a business combination within the required timeframe.

The company’s Class A ordinary shares give public investors exposure to the search for a merger partner rather than to an established stream of revenue or earnings. Like other SPACs, Churchill Capital Corp XI is expected to hold IPO proceeds in a trust account while management evaluates potential acquisition candidates. Investors typically focus on the size and quality of the trust, redemption rights, deal terms, sponsor incentives, and the experience of the team behind the vehicle.

Churchill Capital Corp XI belongs to the broader Churchill Capital SPAC franchise, a platform associated with large-scale public-market acquisition vehicles. The company may consider targets across a wide range of industries unless its governing documents or public filings specify a narrower mandate. Until a transaction is announced, the stock is primarily driven by cash-in-trust dynamics, market expectations around the sponsor, and any news about a potential combination. After a merger agreement is signed, the investment case shifts toward the operating profile, valuation, growth prospects, and risks of the proposed target business.

10.22 USD
+0.04 (+0.34%)

Last updated

Market Cap
P/E
P/FCF
P/S
Enterprise Value
Sector
Industry
Address
640 FIFTH AVENUE 12TH FLOOR, NEW YORK, NY, 10019
GlobeNewswire Inc.

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

17 Oct 2022, 16:30 PM
Zacks Investment Research

Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?

06 Oct 2022, 17:40 PM
GlobeNewswire Inc.

ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

05 Oct 2022, 16:30 PM
Zacks Investment Research

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

26 Sep 2022, 14:20 PM
Zacks Investment Research

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

23 Sep 2022, 14:20 PM
Zacks Investment Research

Why Is Ionis Pharmaceuticals (IONS) Down 5.8% Since Last Earnings Report?

08 Sep 2022, 19:30 PM
Zacks Investment Research

Why Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?

07 Sep 2022, 19:30 PM
GlobeNewswire Inc.

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

24 Aug 2022, 16:30 PM
Zacks Investment Research

Here's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buy

16 Aug 2022, 20:00 PM
Zacks Investment Research

ChemoCentryx (CCXI) Now Trades Above Golden Cross: Time to Buy?

16 Aug 2022, 17:55 PM
Zacks Investment Research

The Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals

12 Aug 2022, 14:05 PM
Zacks Investment Research

Biotech Stock Roundup: AMGN's Q2 Earnings, CCXI Acquisition & More Updates

11 Aug 2022, 19:25 PM
MarketWatch

Get ready for more merger mania in the pharma sector for the rest of the year

11 Aug 2022, 15:30 PM
Zacks Investment Research

Ocular Therapeutix (OCUL) Reports Q2 Loss, Lags Revenue Estimates

09 Aug 2022, 01:45 AM
Zacks Investment Research

Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx

05 Aug 2022, 17:45 PM
Zacks Investment Research

ChemoCentryx (CCXI) Moves 109.2% Higher: Will This Strength Last?

05 Aug 2022, 15:29 PM
Zacks Investment Research

Will Brickell (BBI) Report Negative Earnings Next Week? What You Should Know

04 Aug 2022, 18:00 PM
GlobeNewswire Inc.

ChemoCentryx to Hold Second Quarter 2022 Financial Results Conference Call on Tuesday, August 9, 2022

03 Aug 2022, 00:05 AM
Zacks Investment Research

ChemoCentryx's (CCXI) Tavneos Aids Growth, Overdependence a Woe

05 Jul 2022, 20:53 PM
GlobeNewswire Inc.

ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director

05 Jul 2022, 16:30 PM

Financial statements are not available for this listing.

Kind Filing Date Link
edgar index 10-Q — Churchill Capital Corp XI View Filing
edgar index SCHEDULE 13G/A — Churchill Capital Corp XI View Filing
edgar index 10-K — Churchill Capital Corp XI View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 3 — Churchill Capital Corp XI View Filing
edgar index 3 — Churchill Capital Corp XI View Filing
edgar index 8-K — Churchill Capital Corp XI View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — Churchill Capital Corp XI View Filing
edgar index SCHEDULE 13G — Churchill Capital Corp XI View Filing
edgar index SCHEDULE 13G — Churchill Capital Corp XI View Filing
edgar index SCHEDULE 13G/A — Churchill Capital Corp XI View Filing
edgar index SCHEDULE 13G — Churchill Capital Corp XI View Filing
edgar index 8-K — Churchill Capital Corp XI View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13D — Churchill Capital Corp XI View Filing
edgar index SCHEDULE 13G — Churchill Capital Corp XI View Filing
edgar index 8-K — Churchill Capital Corp XI View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — Churchill Capital Corp XI View Filing
edgar index 8-K — Churchill Capital Corp XI View Filing
edgar index 4 — Churchill Capital Corp XI View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — M. Klein Associates, Inc. View Filing
form 4 Form 4 — CHURCHILL SPONSOR XI LLC View Filing
form 4 Form 4 — Klein Michael Stuart View Filing
edgar index 424B4 — Churchill Capital Corp XI View Filing
edgar index 8-A12B — Churchill Capital Corp XI View Filing
edgar index S-1MEF — Churchill Capital Corp XI View Filing
edgar index 3 — Churchill Capital Corp XI View Filing
edgar index 3 — Churchill Capital Corp XI View Filing
edgar index 3 — Churchill Capital Corp XI View Filing
edgar index CERT — Churchill Capital Corp XI View Filing
edgar index EFFECT — Churchill Capital Corp XI View Filing
form 3 Form 3 — M. Klein Associates, Inc. View Filing
form 3 Form 3 — CHURCHILL SPONSOR XI LLC View Filing
form 3 Form 3 — Klein Michael Stuart View Filing
edgar index S-1/A — Churchill Capital Corp XI View Filing
edgar index S-1 — Churchill Capital Corp XI View Filing
edgar index DRS — Churchill Capital Corp XI View Filing